Edition:
United Kingdom

Torrent Pharmaceuticals Ltd (TORP.NS)

TORP.NS on National Stock Exchange of India

1,806.10INR
8:08am GMT
Change (% chg)

Rs43.65 (+2.48%)
Prev Close
Rs1,762.45
Open
Rs1,765.00
Day's High
Rs1,823.60
Day's Low
Rs1,754.45
Volume
275,615
Avg. Vol
277,566
52-wk High
Rs1,872.80
52-wk Low
Rs1,221.20

Latest Key Developments (Source: Significant Developments)

FDA Provides Update On Its Ongoing Investigation Into Valsartan Products
Thursday, 13 Sep 2018 

Sept 13 (Reuters) - Torrent Pharmaceuticals Ltd ::FDA PROVIDES UPDATE ON ITS ONGOING INVESTIGATION INTO VALSARTAN PRODUCTS.FDA SAYS LATEST TESTING OF PRODUCTS SHOWS AN ADDITIONAL UNEXPECTED IMPURITY IN 3 LOTS OF TORRENT PHARMACEUTICALS’ RECALLED VALSARTAN DRUG PRODUCTS.FDA SAYS N-NITROSODIETHYLAMINE IMPURITY WAS FOUND IN TORRENT’S VALSARTAN 160MG (LOT BV47D001) AND 320MG (LOTS BV48D001 AND BV48D002) TABLETS.  Full Article

India's Torrent Pharma June Qtr Consol Profit Falls
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Torrent Pharmaceuticals Ltd ::JUNE QUARTER CONSOL NET PROFIT 1.63 BILLION RUPEES VERSUS PROFIT OF 1.88 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR JUNE QUARTER CONSOL NET PROFIT WAS 1.61 BILLION RUPEES.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 18.72 BILLION RUPEES VERSUS 13.62 BILLION RUPEES LAST YEAR.  Full Article

India's Torrent Pharmaceuticals March Qtr Consol Profit Up About 11 Pct
Wednesday, 30 May 2018 

May 30 (Reuters) - Torrent Pharmaceuticals Ltd ::MARCH QUARTER CONSOL NET PROFIT 2.28 BILLION RUPEES VERSUS PROFIT OF 2.06 BILLION RUPEES LAST YEAR.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 17.22 BILLION RUPEES VERSUS 14.34 BILLION RUPEES LAST YEAR.DECLARED FINAL DIVIDEND OF 5 RUPEES PER SHARE.  Full Article

Torrent Pharmaceuticals ‍To Consider Raising Of Funds
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Torrent Pharmaceuticals Ltd ::TO CONSIDER RAISING OF FUNDS VIA ISSUE OF SHARES INCLUDING CONVERTIBLE BONDS / DEBENTURES THROUGH QIP OR OTHER MODES​.‍TO CONSIDER RAISING OF FUNDS VIA ISSUE OF NCDS/BONDS VIA PRIVATE PLACEMENT ​.  Full Article

Torrent Pharmaceuticals Buys Bio-Pharm Inc
Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Torrent Pharmaceuticals Ltd ::SAYS TORRENT PHARMA ACQUIRES BIO-PHARM INC.PLANS FURTHER INVESTMENTS TO EXPAND BIO-PHARM FACILITIES; WILL INCREASE NUMBER OF PRODUCT FILINGS FROM BIO-PHARM.  Full Article

‍Torrent Pharma buys branded business of India & Nepal from Unichem
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Torrent Pharmaceuticals Ltd ::‍Torrent Pharma acquires branded formulation business of India and Nepal of Unichem Laboratories Limited​.Says deal for 36 billion rupees‍​.Says will fund deal through mix of internal accruals, bank borrowings‍​.Says deal is ongoing concern basis by way of slump sale.Says about 3000 plus employess will get added to Torrent's existing employee pool.Deal is expected to close by end of 2017‍​.  Full Article

India's Torrent Pharmaceuticals Sept-qtr consol profit down 1.4 pct
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Torrent Pharmaceuticals Ltd ::Sept quarter consol net profit 2.04 billion rupees versus profit of 2.07 billion rupees last year.Consensus forecast for Sept quarter consol net profit was 2.17 billion rupees.Sept quarter consol net sales 14.01 billion rupees versus 14.06 billion rupees last year.  Full Article

UPDATE 1-EU places China's Zhejiang Huahai under increased supervision

Oct 15 European authorities are placing Zhejiang Huahai Pharmaceutical Co Ltd under higher supervision, the European Medicines Agency said on Monday, in the latest crackdown on the Chinese firm after a probable carcinogen was found in its blood pressure drug valsartan.